stem cell treatment in Australia

Stem cell therapy has within a short span of time provided a ray of hope to many patients who are suffering with different chronic diseases, injuries and degenerative disorders. In Australia, this revolutionary treatment is getting massive interest due to the chance to reshape the quality of life of people who failed alternative treatment options. […]

MD is a category of symptomatic hereditary diseases that result in muscular wasting and functional disability that become worse over time. Largely due to progressive muscles’ atrophy, MD makes the management of mobility and independence complicated, degrading it as one of the most disabling diseases. Although it may be possible to alleviate manifestations of the

Motor Neuron Disease (MND) is a clinical syndrome of Neurodegenerative disorders that is characterized by the death of motor neurons in the cerebral cortex, brain stem and spinal cord. This leads to the motor dysfunction of muscles bordering on immobility; respiratory and swallowing problems. The need for relief from the illness has forced a search

Stargardt’s or macular dystrophy leads to the deterioration of the macula. Conventional interventions such as pharmacotherapy and the use of low-vision devices have only provided paltry relief and therefore emphasize the need for improved treatments. This is the reason why there is so much hope and expectations from stem cell therapy. Combined with proteolytic enzyme

Retinitis pigmentosa (RP) is an inherited disease of the retina. This results in the breakdown of photoreceptor cells which are present in the retina. Let us explore specific features of RP treatment in Australia and discuss how the opportunities of stem cell therapy influence the development of treatment strategies for this complex disease. Personalized Stem